Cdk Inhibitor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CYCCP | F | Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 2.74 | |
CYCC | F | Cyclacel Pharmaceuticals, Inc. | -3.41 |
Related Industries: Biotechnology
Related Stock Lists:
Autoimmune And Inflammatory Disease
Biology
Biopharmaceutical
Cancer
Cancer Cell
Cell Biology
Cell Cycle
Cell Cycle Checkpoint
Cyclacel
Cyclin Dependent Kinase
Cyclin Dependent Kinase 2
Dna Synthesis
Human Cancers
Inflammatory Diseases
PLK1
Sapacitabine
Seliciclib
Treatment Of Cancer
Related Industries:
Biotechnology
Related Stock Lists:
Autoimmune And Inflammatory Disease
Biology
Biopharmaceutical
Cancer
Cancer Cell
Cell Biology
Cell Cycle
Cell Cycle Checkpoint
Cyclacel
Cyclin Dependent Kinase
Cyclin Dependent Kinase 2
Dna Synthesis
Human Cancers
Inflammatory Diseases
PLK1
Sapacitabine
Seliciclib
Treatment Of Cancer
- Cdk Inhibitor
CDK inhibitors are drugs that block the activity of cyclin-dependent kinases (CDKs), which are enzymes that play a key role in cell division. CDK inhibitors are used to treat certain types of cancer, as they can stop cancer cells from dividing and growing. They can also be used to treat other conditions, such as autoimmune diseases.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles